期刊文献+

综合重症监护病房主要致病菌的菌群分布及其药敏分析

Major Pathogenic Bacteria Distribution in Comprehensive ICU and Analysis of Corresponding Drug Sensitivity
下载PDF
导出
摘要 目的:了解我院综合重症监护病房主要致病菌的菌群分布及其耐药性状况,为危重患者抗菌药物的合理应用提供依据。方法:对我院ICU 2001年1月至2004年12月所分离致病菌的菌群分布及耐药情况进行回顾性分析。结果:455例标本进行细菌培养,阳性279例。其中阳性率最高的是大肠埃希菌53例次,其它依次是铜绿假单胞菌50例次、金葡菌46例次、白假丝酵母菌33例次和阴沟肠杆菌11例次等。革兰阴性致病杆菌对亚胺培南、头孢哌酮和(或)舒巴坦、头孢他啶敏感性较高;革兰阳性致病球菌对万古霉素、替考拉宁、氯霉素、利福平的敏感性较高。结论:熟悉ICU主要致病菌的菌群分布及其耐药性状况非常重要,对危重感染患者早期合理经验性选用抗菌药物、提高危重病患者救治成功率具有重要意义。 Objective:To explore the distribution of major pathogenic bacteria in our comprehensive ICU and the condition of drug tolerance,to supply reasonable applied evidence of antibiotic drugs for intensive patients.Methods:To analysis the distribution of major pathogenic bacteria and the condition of drug tolerance in the comprehensiv ICU from January 2001 to December 2004 retrospectively.Results: 279 samples showed positive of total 455 ones undergoing bacterial culture.The most frequent positive sample was Escherichia coli(53 samples),followed by Pseudomonas aeruginosa(50 samples),Staphylococcus aureus (46 samples),Candida albicans(33 samples) and Aerobacter cloacae(11 samples). Gram-negative pathogenic bacillus showed sensitivity to Imipenem,Cefoperazone/ Sulbactam and Ceftazidime.Gram-positive pathogenic coccus was sensitive to Vancomycin,Teicoplanin,Chloramphenicol and Rifampicin.Conclusions:It's essential to familiarize the distribution of major pathogenic bacteria in ICU and drug tolerance condition,which plays a significant role on the early reasonable application of antibiotics and on the successful rescue for intensive infectious patients.
出处 《现代临床医学》 2007年第3期173-174,共2页 Journal of Modern Clinical Medicine
关键词 重症监护病房 细菌培养 药敏试验 抗生素 ICU bacterial culture drug sensitive test antibiotics
  • 相关文献

参考文献4

二级参考文献19

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2Valero C, Garcia Palomo JD, Matorras P, et al. Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Inter Medicine,2001,12:425-429.
  • 3Corona-Nakamura AL, Miranda-Novales MG, Leanos-Miranda B, et al. Epidemiologyic study of Pseudomonas aeruginosa in critical patients and reservoirs. Archives Medical Res,2001,32:238-242.
  • 4Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 5Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 6Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 7Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 8National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 9Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 10张秀珍,王辉,胡云健,谢秀丽,徐英春,陈民钧,周贵民,吴坚,许淑珍,张淑兰,王清涛,杜小玲.北京五家医院5374株菌对18种抗生素的敏感性[J].中华医学杂志,1997,77(7):543-544. 被引量:26

共引文献698

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部